clomipramine

1
Reactions 455 - 12 Jun 1993 S Clomipramine First report of concurrent agranulocytosis and hepatitis in an elderly patient: case report A 67-year-old man with depression developed severe agranulocytosis and hepatitis following treatment with clomipramine 175 mg/day. One month after starting clomipramine, tests revealed anaemia, leucopenia and grossly elevated hepatic transaminase levels. Three days after withdrawal of clomipramine and piroxicam, which he had been taking for 18 months to treat osteoarthritis, a bone marrow examination showed profound granulocytic hypoplasia consistent with drug-induced neutropenia. At this stage, his WBC was 1 x 10 sup(9)/L with 1.36% neutrophils. The biochemical and blood disturbances normalised over the following 2-week period when his WBC rose to 4.6 x 10 sup(9)/L with 53% neutrophils Author comment: ‘Of interest in this case report is the concurrent appearance of serious agranulocytopenia and elevation of hepatic transaminases, which has not previously been reported with clomipramine or other TCAs (tricyclic antidepressants).’ Alderman CP, et al. Concurrent agranulocytosis and hepatitis secondary to clomipramine therapy. British Journal of Psychiatry 162: 688-689, May 1993 - Australia 800199404 1 Reactions 12 Jun 1993 No. 455 0114-9954/10/0455-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Upload: trankhue

Post on 18-Mar-2017

216 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Clomipramine

Reactions 455 - 12 Jun 1993

★ SClomipramine

First report of concurrent agranulocytosis andhepatitis in an elderly patient: case report

A 67-year-old man with depression developed severeagranulocytosis and hepatitis following treatment withclomipramine 175 mg/day. One month after startingclomipramine, tests revealed anaemia, leucopenia and grosslyelevated hepatic transaminase levels. Three days afterwithdrawal of clomipramine and piroxicam, which he hadbeen taking for 18 months to treat osteoarthritis, a bonemarrow examination showed profound granulocytichypoplasia consistent with drug-induced neutropenia. At thisstage, his WBC was 1 x 10 sup(9)/L with 1.36% neutrophils.The biochemical and blood disturbances normalised over thefollowing 2-week period when his WBC rose to 4.6 x 10sup(9)/L with 53% neutrophils Author comment: ‘Of interest inthis case report is the concurrent appearance of seriousagranulocytopenia and elevation of hepatic transaminases,which has not previously been reported with clomipramine orother TCAs (tricyclic antidepressants).’Alderman CP, et al. Concurrent agranulocytosis and hepatitis secondary toclomipramine therapy. British Journal of Psychiatry 162: 688-689, May 1993 -Australia 800199404

1

Reactions 12 Jun 1993 No. 4550114-9954/10/0455-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved